Bsx nyse.

Boston Scientific (NYSE:BSX – Get Free Report) had its price objective upped by research analysts at Canaccord Genuity Group from $60.00 to $64.00 in a research report issued on Monday, Benzinga reports. The firm presently has a “buy” rating on the medical equipment provider’s stock. Canaccord Genuity Group’s price target would suggest a potential upside […]Dec 1, 2023Nov 27, 2023 · Boston Scientific Insider Sold Shares Worth $632,269, According to a Recent SEC Filing. Nov. 16. MT. Transcript : Boston Scientific Corporation Presents at The Stifel 2023 Annual Healthcare Conference, Nov-14-2023 08:00 AM. Nov. 14. Find the latest Boston Scientific Corporation (BSX) stock quote, history, news and other vital information to help you with your stock trading and investing.Boston Scientific Corporation (NYSE:BSX) entered into a definitive merger agreement to acquire Apollo Endosurgery, Inc. (NasdaqGM:APEN) for approximately $440 million. Nov 30 Boston Scientific Corporation Announces the First Results from the ACURATE neo2 Post Market Clinical Follow-up (PMCF) Study

21 Apr, 2020, 08:00 ET. MARLBOROUGH, Mass., April 21, 2020 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has signed a virtual power purchase agreement (VPPA) that represents the ...Bloomberg News reported on April 21 that Boston Scientific, which has a market value of about $77 billion, may buy Shockwave Medical, a maker of artery-clearing devices with a market capitalization of about $10 billion. The report cited people familiar with the matter. With $570 million in cash on hand at the end of March, according to a …Web

MARLBOROUGH, Mass., Sept. 6, 2018 / PRNewswire / -- Boston Scientific (NYSE: BSX) today announced that it has entered into a definitive agreement to acquire Augmenix, Inc., a privately-held company which has developed and commercialized the SpaceOAR ® System, a therapy used to reduce common and debilitating side effects …Web1. Confirmed cup and handle pattern on BSX chart Hi, please see the following chart pattern, that has been confirmed in the last weeks. Accordingly to the rules of the pattern, the …

Dec 4, 2023 · Boston Scientific last released its quarterly earnings results on October 26th, 2023. The medical equipment provider reported $0.50 earnings per share for the quarter, beating analysts' consensus estimates of $0.48 by $0.02. The company earned $3.53 billion during the quarter, compared to the consensus estimate of $3.48 billion. 16 Wall Street research analysts have issued 1 year price targets for Boston Scientific's shares. Their BSX share price targets range from $55.00 to $66.00. On average, they anticipate the company's share price to reach $60.55 in the next year. This suggests a possible upside of 8.7% from the stock's current price.Boston Scientific Corp stock price (BSX) NYSE: BSX. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Boston Scientific Corp stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. Select a stock.After a 13% fall year-to-date, at the current levels, we believe Boston Scientific stock (NYSE: BSX) is undervalued. BSX stock fell from around $43 in early January to under $38 now.

May 20, 2023 · MARLBOROUGH, Mass., May 20, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced data supporting use of the company's key electrophysiology and cardiac rhythm management ...

Aug 15, 2022 · MARLBOROUGH, Mass., Aug. 15, 2022 / PRNewswire / -- Boston Scientific Corporation (NYSE: BSX) today announced the acquisition of Obsidio, Inc., a privately-held company that has developed the Gel Embolic Material (GEM ™) technology used for embolization of blood vessels in the peripheral vasculature. Embolization is a minimally invasive ...

MARLBOROUGH, Mass., Sept. 6, 2018 / PRNewswire / -- Boston Scientific (NYSE: BSX) today announced that it has entered into a definitive agreement to acquire Augmenix, Inc., a privately-held company which has developed and commercialized the SpaceOAR ® System, a therapy used to reduce common and debilitating side effects …WebBoston Scientific (NYSE:BSX) announced today that it completed the nearly $1.1 billion acquisition of the global surgical business of Lumenis. Marlborough, Massachusetts–based Boston Scientific ...Boston Scientific stock (NYSE: BSX) currently trades at $51 per share, roughly 30% above its level in March 2021, and it now seems to be fully valued. Boston Scientific BSX 0.0% saw its stock ...BSX: Get the latest Boston Scientific stock price and detailed information including BSX news, historical charts and realtime prices. Indices Commodities Currencies StocksBoston Scientific last released its quarterly earnings results on October 26th, 2023. The medical equipment provider reported $0.50 earnings per share for the quarter, beating analysts' consensus estimates of $0.48 by $0.02. The company earned $3.53 billion during the quarter, compared to the consensus estimate of $3.48 billion.

Boston Scientific Corporation (NYSE: BSX) was in 58 hedge funds' portfolios at the end of December. The all time high for this statistic is 66. Our calculations also showed that BSX isn't among ...WINTON GROUP Ltd boosted its holdings in shares of Boston Scientific Co. ( NYSE:BSX – Free Report) by 294.2% during the 2nd quarter, according to its most recent 13F filing with the Securities ...Interactive Brokers. Visualize o gráfico de Boston Scientific Corporation ao vivo para acompanhar o movimento do preço de suas ações. Encontre previsões de mercado, …Nov 27, 2023 · Boston Scientific Insider Sold Shares Worth $632,269, According to a Recent SEC Filing. Nov. 16. MT. Transcript : Boston Scientific Corporation Presents at The Stifel 2023 Annual Healthcare Conference, Nov-14-2023 08:00 AM. Nov. 14. BSX (U.S.: NYSE) Overview News Boston Scientific Corp. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) 68.77 ( 12/01/23) EPS (TTM) $0.82 Market Cap $82.24 B...27 Jul 2023 ... PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.599 billion during the second quarter of 2023, ...

Dec 4, 2023 · Boston Scientific last released its quarterly earnings results on October 26th, 2023. The medical equipment provider reported $0.50 earnings per share for the quarter, beating analysts' consensus estimates of $0.48 by $0.02. The company earned $3.53 billion during the quarter, compared to the consensus estimate of $3.48 billion.

Nov 6, 2023 · Boston Scientific Corp. (NYSE:BSX) trade information. Instantly BSX has been showing a green trend so far today with a performance of 0.09% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 53.10 on Friday, 11/03/23 increased the stock’s daily price by 0.98%. Boston Scientific Closes Acquisition of Relievant Medsystems, Inc. Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Relievant Medsystems Inc., a company that offers the only U.S. Food and Drug Administration-cleared Intracept® Intraosseous Nerve Ablation System, a therapy to treat vertebrogenic pain …The latest price target for . Boston Scientific (NYSE: BSX) was reported by Canaccord Genuity on Monday, November 27, 2023.The analyst firm set a price target for 64.00 expecting BSX to rise to ...0.73%. $23.63B. Teleflex Inc. 0.65%. $10.33B. BSX | Complete Boston Scientific Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Nov 7, 2023 · What is BSX’s CCI (14)? Get a technical analysis of Boston Scientific (BSX) with the latest MACD of 0.05 and RSI of 59.46. Stay up-to-date on market trends with our expert analysis. 9 Nov 2023 ... Boston Scientific (NYSE: BSX) reported its Q3 results last month, with revenues and earnings beating the street estimates.53.68. 7,007,800. *Close price adjusted for splits. **Close price adjusted for splits and dividend and/or capital gain distributions. Discover historical prices for BSX stock on Yahoo Finance. View daily, weekly or monthly formats back to when Boston Scientific Corporation stock was issued.WebBy Ben Hobson. • 07 Sept 2020. The Boston Scientific (NYSE:BSX) share price has risen by 9.94% over the past month and it’s currently trading at 41.48. For investors considering whether to buy, hold or...Web

MARLBOROUGH, Mass., Aug. 19, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the completion of its acquisition of BTG plc.(LSE: BTG) pursuant to the previously ...

Boston Scientific Corp. (NYSE: BSX)’s stock price has gone rise by 0.22 in comparison to its previous close of 55.43, however, the company has experienced a 1.61% increase in its stock price over the last five trading days. The Motley Fool reported 2023-11-25 that Ozempic could make some medical devices less necessary than before. If that ...

Overview Stock Screener Earnings Calendar Sectors NYSE | BSX U.S.: NYSE Boston Scientific Corp. Watch NEW Set a price target alert Premarket Last Updated: Nov 30, …Boston Scientific Corp (BSX). 56.14 +0.25 (+0.45%) USD | NYSE | Dec 01, 16: ...Boston Scientific stock (NYSE: BSX) has seen a fall of 3% in a month, compared with -5% returns for the broader S&P500 index. The company reported mixed Q4 results last month, with revenue falling ...Dec 4, 2023 · Rock Springs Capital Management LP acquired a new position in shares of Boston Scientific Co. (NYSE:BSX - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 267,500 shares of the medical equipment provider's stock, valued at ... Boston Scientific Corp. (NYSE:BSX) trade information. Boston Scientific Corp. (BSX) registered a 0.25% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 0.25% in intraday trading to $51.56 this Friday, 11/10/23, hitting a weekly high.Potentially undervalued companies in the Healthcare industry. View Future Growth. Research Boston Scientific's (NYSE:BSX) stock key valuation metrics while comparing it …The public float for BSX is 1.46B, and at present, short sellers hold a 0.63% of that float. On November 17, 2023, the average trading volume of BSX was 8.51M shares. BSX) stock’s latest price update. Boston Scientific Corp. (NYSE: BSX) has seen a rise in its stock price by 1.52 in relation to its previous close of 53.85.Boston Scientific Corp. (NYSE: BSX) Q3 2022 earnings call dated Oct. 26, 2022 Corporate Participants: Lauren Tengler -- Vice President, Investor Relations Michael F. Mahoney -- Chairman and Chief Executive Officer Daniel J. Brennan -- Executive Vice President and Chief Financial Officer Ken Stein -- Vice President, Chief Medical Officer …WebDec 1, 2023 · Financial Performance. In 2022, BSX's revenue was $12.68 billion, an increase of 6.68% compared to the previous year's $11.89 billion. Earnings were $642.00 million, a decrease of -34.82%. Financial Statements. Boston Scientific Corporation (NYSE:BSX) Q4 2022 Results Conference Call February 1, 2023 8:00 AM ETCompany Participants. Lauren Tengler - Vice President, Investor Relations. Mike Mahoney ...APP Sindical Baixe nosso aplicativo! Emissão de Boletos Contribua com o sindicato e fortaleça a categoria. CCTS e ACTs Baixe todas as nossas convenções coletivas e …Boston Scientific Corporation (NYSE:BSX) is an established medical device manufacturer, with a strong global presence across many different medical specialties, yet has been following a growth ...

Boston Scientific (NYSE: BSX) ... BSX stock is trading at 27x forward P/E based on our earnings forecast of $1.92 for 2023, compared to the last three-year average of 24x, implying that BSX stock ...Boston Scientific Corp stock price (BSX) NYSE: BSX. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Boston Scientific Corp stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. Select a stock.Boston Scientific has a total shareholder equity of $19.1B and total debt of $8.9B, which brings its debt-to-equity ratio to 46.5%. Its total assets and total liabilities are $34.0B and $14.9B respectively. Boston Scientific's EBIT is $2.3B making its interest coverage ratio 9.2. It has cash and short-term investments of $952.0M.Instagram:https://instagram. vanguard total corporate bond etf1 yr t billlist of dow stocksaffirm target NYSE: Boston Scientific Corp (BSX) = 55.89 USD. Provided by Alpha Vantage. Boston Scientific Corp stock (BSX) in USD. 1 BSX = 55.89 USD. 1 tháng. 6 tháng. 1 year. 5 năm. Hold over 40 currencies to convert and send money at any time. Open an account. Boston Scientific Corp stock performance at a glance.WebNov 8, 2023 · Boston Scientific Co. (NYSE:BSX) Stock Position Increased by Acadian Asset Management LLC 11/10/2023 - Ticker Report Boston Scientific Co. to Post Q1 2025 Earnings of $0.63 Per Share, Zacks Research Forecasts (NYSE:BSX) dis chemvangaurd 2050 Past criteria checks 4/6. Boston Scientific's earnings have been declining at an average annual rate of -22.2%, while the Medical Equipment industry saw earnings growing at 9.7% annually. Revenues have been growing at an average rate of 7% per year. Boston Scientific's return on equity is 6.4%, and it has net margins of 8.7%.Blackstone Minerals Limited (BSX) has a current dividend yield of n/a this year. Last year's dividend yield was 0%. The dividend yield for BSX is a ratio that tells you the percentage of Blackstone Minerals Limited's (BSX) share price that it pays out in dividends each year.Web tcnnf stock forecast 53.68. 7,007,800. *Close price adjusted for splits. **Close price adjusted for splits and dividend and/or capital gain distributions. Discover historical prices for BSX stock on Yahoo Finance. View daily, weekly or monthly formats back to when Boston Scientific Corporation stock was issued.Web28 Apr, 2021, 06:30 ET. MARLBOROUGH, Mass., April 28, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.752 billion during the first quarter of 2021. This ...Sep 1, 2021 · Boston Scientific (NYSE:BSX) announced today that it completed the nearly $1.1 billion acquisition of the global surgical business of Lumenis.. Marlborough, Massachusetts–based Boston Scientific ...